Get started

Parabolic

ALGO - The Beast Is Awakened!Algorand, or what I called " the sleeping giant " is finally awakened. As per my previous analysis (attached below), we have been waiting for a confirmation to buy ALGO around the support 0.700 ALGO activated the buy and traded higher aggressively . This movement reminded me of FTM and how its parabolic movement started. NOW WHAT? ALGO broke above the 1.8 - 2.0 resistance zone so it is now acting as support and we will be looking for buy setups on its retest. Our next rejection / resistance area would be 2.8 - 3.0. Always follow your trading plan regarding entry, risk management, and trade management. Good luck! All Strategies Are Good; If Managed Properly! ~Rich
BINANCE:ALGOUSDLong
by TheSignalyst
22
$SRZNCommon stock and warrants to commence trading on Nasdaq on August 12, 2021 under the ticker symbols SRZN and SRZNW SOUTH SAN FRANCISCO, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) — Surrozen, Inc. (“Surrozen”), a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration, today announced the completion of its business combination with Consonance-HFW Acquisition Corp. (“Consonance-HFW”), a special purpose acquisition company (“SPAC”) sponsored by entities affiliated with Consonance Capital Management. The resulting combined company will commence trading its shares on Nasdaq under the ticker symbol “SRZN” and its warrants under the ticker symbol “SRZNW” on August 12, 2021. The shareholders of Consonance-HFW approved the transaction at an extraordinary general meeting held on August 10, 2021, and the transaction was previously approved by Surrozen’s stockholders. Surrozen’s management team, led by President and Chief Executive Officer, Craig Parker, will continue to lead the combined company. Craig Parker, President and Chief Executive of Officer of Surrozen, commented, “We have long known the importance of the Wnt pathway as the body’s own mechanism for tissue repair but harnessing its promise for therapeutic applications remained out of reach for drug developers until recently. We believe Surrozen has the potential to unlock the promise of the Wnt pathway and transform treatment of multiple serious diseases.” He further commented, “The capital raised from the successful completion of this transaction, along with our strategy to accelerate the development of our innovative programs, will help us bring this vision to life.” Gad Soffer, Chief Executive Officer of Consonance-HFW, commented, “We are proud to partner with Surrozen in hopes of providing breakthrough therapies in areas of high unmet need.” He added, “By combining experienced industry leaders with an innovative approach to harness the therapeutic potential of the Wnt pathway, we believe Surrozen is well positioned in its efforts to transform treatments for serious diseases.” About this Transaction On April 15th, 2021, Surrozen, a privately held biotechnology company, entered into a definitive business combination agreement with Consonance-HFW, a special purpose acquisition company (SPAC) that was created for the purpose of entering into a business combination with a selected life sciences company. The description of the business combination contained herein is only a high-level summary and is qualified in its entirety by reference to the underlying documents filed with the U.S. Securities and Exchange Commission. A more detailed description of the terms of the transaction has been provided in a registration statement on Form S-4 filed with the U.S. Securities and Exchange Commission by Consonance-HFW. Transaction Advisors J.P. Morgan Securities LLC is acting as financial advisor to Consonance-HFW in connection with the business combination, and J.P. Morgan Securities LLC and BofA Securities are acting as placement agents on behalf of Consonance-HFW. Guggenheim Securities, LLC is acting as financial advisor and capital markets advisor to Surrozen, and Stifel, Nicolaus & Company, Incorporated is acting as capital markets advisor to Surrozen in the transaction. Goodwin Procter LLP is acting as legal counsel to Consonance-HFW, Cooley LLP is acting as legal counsel to Surrozen and Wilson Sonsini Goodrich & Rosati, P.C. is acting as legal counsel to the placement agents. About Consonance-HFW Acquisition Corp. Consonance-HFW Acquisition Corp. is a recently incorporated blank check company incorporated as a Cayman Islands exempted company and incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. It is led by Chairman Mitchell Blutt, M.D., Chief Executive Officer Gad Soffer, Chief Financial Officer Kevin Livingston and VP Business Development Joshua House. About Consonance Capital Management Consonance Capital Management was founded in 2007 with approximately $50 million of assets under management by Mitchell Blutt, Benny Soffer and Kevin Livingston. As of March 31, 2021, the fund has grown to approximately $1 billion in assets under management and focuses on equity investments in life sciences companies, with an emphasis on small and mid-cap life sciences companies. About Surrozen Surrozen is a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway. Surrozen is developing tissue-specific antibodies designed to engage the body’s existing biological repair mechanisms with potential application across multiple disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas and central nervous system.
NASDAQ:SRZNLong
by BADQOMOCAWGOWLD
$HLBZHelbiz Inc. provides micro-mobility services. The company offers a fleet of vehicles, including e-scooters, e-bicycles, and e-mopeds all on one convenient platform in 35 cities worldwide. It utilizes a customized, proprietary fleet management platform, artificial intelligence, and environmental mapping to optimize operations and business sustainability. The company also focuses on expanding its urban lifestyle products and services to include live streaming services, food delivery, financial services, and others accessible within its mobile app. The company was incorporated in 2015 and is headquartered in New York, New York.
HLong
by BADQOMOCAWGOWLD
3
$GANX Gain Therapeutics, Inc., a development stage biotechnology company, develops various therapeutics to treat diseases caused by protein misfolding. It focuses on lysosomal storage disorders, such as rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover novel allosteric sites on misfolded proteins and identify proprietary small molecules that bind these sites and restore protein folding treating the underlying disease. It is developing structurally targeted allosteric regulator candidates to treat various diseases, including Morquio B, GM1 gangliosidosis (GM1), neuronopathic Gaucher disease, GBA1 Parkinson's, Krabbe, and Mucopolysaccharidosis type 1 diseases. The company was founded in 2017 and is based in Bethesda, Maryland.
NASDAQ:GANXLong
by BADQOMOCAWGOWLD
$SKLZSkillz Inc. operates as a technology company that enables game developers to monetize their content through fun and fair multi-player competition. The company primarily develops and supports a proprietary online-hosted technology platform that enables independent game developers to host tournaments and provide competitive gaming activity to end-users worldwide. It hosts casual esports tournaments to a range of mobile players. The company was founded in 2012 and is headquartered in San Francisco, California.
NYSE:SKLZLong
by BADQOMOCAWGOWLD
$PFE Long term PT 300 and higher$PFE Lepas Calls 70 Jun 16th 2023 Returns +10,125% $BNTX and $PFE Leaps The FDA approval of Pfizer’s COVID-19 vaccine is a ‘critical step forward in vaccine confidence’: Doctor Army gives Pfizer $3.5B contract to make 500 million COVID vaccine doses Pfizer authorizes $1 billion for oral COVID-19 treatment, CEO says Pfizer now expects its Covid vaccine to generate $33.5 billion in full-year sales, the company said Wednesday. Pfizer Is Ready, Even For COVID-19 Variants CDC NOW ADVISING STATES TO PREPARE TO DISTRIBUTE THE COVID-19 VACCINE AS SOON AS LATE OCTOBER
NYSE:PFELong
by BADQOMOCAWGOWLD
1
REEF/USDT Parabolic recovery incoming? Signs are flashingREEF starts some serious recovery and did now break upwards the 0.0165$. We now were in a downtrend for at least three months. If we can break this trend and head towards an uptrend we expect to hit the 0.05$ line soon again. The next potential resistance is still 20% away. Daily chart on the left hand side: - We see a strong recovery which could take some more weeks according to the current price position and the recent ATH . - On the RSI side we passed the 70 line which is a warning flag that we go up very fast. - Volume increases steadily which is a bullish sign. 4h chart on the right hand side: - We see a golden cross indicated by the yellow camera. - The RSI is close the 80 line which could be a sign for an upcoming cooldown phase. The pullback however is not expected to go below 60 according to the yellow line. Basic rules: - Never buy the top/ ATH - Take profit as long as you can (also partial profit is profit) - Use Stop/loss for leveraged positions - If you are not experienced, don't leverage in the first place Enjoy the ride and don't be too greedy. If you like the content, please like, comment and give this channel a follow. We would love it if you could share your thoughts in the comments. Discussions are very welcome here. Always do your own research and keep in mind that my charts and comments cannot be considered financial advice. Cheers ps. Chart explanation: Main lines: - Green lines are tested support lines. - Orange lines are resistance lines or, if we are above, possible support lines which were not tested yet. - Cyan line is for volume trendline. - White lines are Fibonacci retracement levels Helplines: - Purple lines are trendlines we take a look at. - Blue, green, white and pink lines are 200MA, 100MA, 50MA and 20MA. - Yellow lines are for visual help only. Boxes: - Either entry zone or support zone . Check the description.
RLong
by tumbler55
3
$EQOS Leaps Calls 7.50 Mar 18th 2022$EQOS entry PTs 5.50-6.10 Target PTs 18- 20-44 and higher...timeline end of Jan $EQOS Leaps Calls 7.50 Mar 18th 2022 (Delta: 0.54 Theta 0.00) Diginex Limited, a digital asset financial services and advisory company, provides products, architecture, and infrastructure for the financial markets in the areas of digital asset ecosystem in Singapore and internationally. The company operates EQONEX, a cryptocurrency exchange that offers the trading of virtual currencies; an over-the-counter trading platform; Digivault, a warm and cold custodian platform for the custody of digital assets for institutional investors; and Access Trading, a digital asset trading tool and front-to-back integrated trading platform, as well as a risk management desk. It also provides asset management services under the Bletchley Park Asset Management name; and EQONEX Capital that assists issuers seeking to access global capital markets through the issuance of either paper securities or digital securities. The company was founded in 2017 and is based in Wan Chai, Hong Kong.
ELong
by BADQOMOCAWGOWLD
EPS/USDT Back on track after another retest of previous supportEllipsis did another retest of the 0.34 line which was unexpected due to the strong recovery right before that. However, we did get a very solid bounce and are again above the violet upwards moving line. Once the 0.53 line is broken we expect a major upwards pump. The strong volume increase during the last 30 days shows rising demand. Just to get near previous ATH we would need more than 2000% from here. So stay patient and enjoy the ride. Basic rules: - Never buy the top/ATH - Take profit as long as you can (also partial profit is profit) - Use Stop/loss for leveraged positions - If you are not experienced, don't leverage in the first place Enjoy the ride and don't be too greedy. If you like the content, please like, comment and give this channel a follow. We would love it if you could share your thoughts in the comments. Discussions are very welcome here. Always do your own research and keep in mind that my charts and comments cannot be considered financial advice. Cheers ps. Chart explanation: Main lines: - Green lines are tested support lines. - Orange lines are resistance lines or, if we are above, possible support lines which were not tested yet. - Cyan line is for volume trendline. - White lines are Fibonacci retracement levels Helplines: - Purple lines are trendlines we take a look at. - Blue, green, white and pink lines are 200MA, 100MA, 50MA and 20MA. - Yellow lines are for visual help only. Boxes: - Either entry zone or support zone. Check the description.
ELong
by tumbler55
3